These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26785153)

  • 1. The endocannabinoid system and neuropathic pain.
    Maldonado R; Baños JE; Cabañero D
    Pain; 2016 Feb; 157 Suppl 1():S23-S32. PubMed ID: 26785153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.
    Donvito G; Nass SR; Wilkerson JL; Curry ZA; Schurman LD; Kinsey SG; Lichtman AH
    Neuropsychopharmacology; 2018 Jan; 43(1):52-79. PubMed ID: 28857069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain.
    Hossain MZ; Ando H; Unno S; Kitagawa J
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cannabinoid system and pain: towards new drugs?].
    Beltramo M
    J Soc Biol; 2009; 203(1):99-106. PubMed ID: 19358815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating the endocannabinoid pathway as treatment for peripheral neuropathic pain: a selected review of preclinical studies.
    O'Hearn S; Diaz P; Wan BA; DeAngelis C; Lao N; Malek L; Chow E; Blake A
    Ann Palliat Med; 2017 Dec; 6(Suppl 2):S209-S214. PubMed ID: 29156899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allodynia Lowering Induced by Cannabinoids and Endocannabinoids (ALICE).
    Luongo L; Starowicz K; Maione S; Di Marzo V
    Pharmacol Res; 2017 May; 119():272-277. PubMed ID: 28237514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy-Induced Neuropathic Pain: Studies in Animal Models.
    Masocha W
    Pain Res Manag; 2018; 2018():5234943. PubMed ID: 30147813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the endocannabinoid system in osteoarthritis pain.
    La Porta C; Bura SA; Negrete R; Maldonado R
    Eur J Neurosci; 2014 Feb; 39(3):485-500. PubMed ID: 24494687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms.
    Wen J; Jones M; Tanaka M; Selvaraj P; Symes AJ; Cox B; Zhang Y
    J Neuroinflammation; 2018 Jan; 15(1):9. PubMed ID: 29310667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the endocannabinoid system in a mouse model of Fragile X undergoing neuropathic pain.
    Ramírez-López A; Pastor A; de la Torre R; La Porta C; Ozaita A; Cabañero D; Maldonado R
    Eur J Pain; 2021 Jul; 25(6):1316-1328. PubMed ID: 33619843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cannabinoids in the management of neuropathic pain.
    Martín Fontelles MI; Goicoechea García C
    CNS Drugs; 2008; 22(8):645-53. PubMed ID: 18601303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions.
    Luongo L; Maione S; Di Marzo V
    Eur J Neurosci; 2014 Feb; 39(3):401-8. PubMed ID: 24494680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.
    Rice AS; Farquhar-Smith WP; Nagy I
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):243-56. PubMed ID: 12052040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidation of pathophysiology and treatment of neuropathic pain.
    Vranken JH
    Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain.
    Klauke AL; Racz I; Pradier B; Markert A; Zimmer AM; Gertsch J; Zimmer A
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):608-20. PubMed ID: 24210682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids and Pain: Sites and Mechanisms of Action.
    Starowicz K; Finn DP
    Adv Pharmacol; 2017; 80():437-475. PubMed ID: 28826543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endogenous cannabinoid system and its role in nociceptive behavior.
    Cravatt BF; Lichtman AH
    J Neurobiol; 2004 Oct; 61(1):149-60. PubMed ID: 15362158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the endocannabinoid system: future therapeutic strategies.
    Aizpurua-Olaizola O; Elezgarai I; Rico-Barrio I; Zarandona I; Etxebarria N; Usobiaga A
    Drug Discov Today; 2017 Jan; 22(1):105-110. PubMed ID: 27554802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
    Lötsch J; Weyer-Menkhoff I; Tegeder I
    Eur J Pain; 2018 Mar; 22(3):471-484. PubMed ID: 29160600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.